|
1
|
Rice TW, Adelstein DJ, Chidel MA, et al:
Benefit of postoperative adjuvant chemoradiotherapy in
locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc
Surg. 126:1590–1596. 2003. View Article : Google Scholar
|
|
2
|
Fayers P and Bottomley A; EORTC Quality of
Life Group; Quality of Life Unit. Quality of life research within
the EORTC-the EORTC QLQ-C30. Eur J Cancer. 38(Suppl 4): 125–133.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olschewski M, Schulgen G, Schumacher M and
Altman DG: Quality of life assessment in clinical cancer research.
Br J Cancer. 70:1–5. 1994. View Article : Google Scholar
|
|
4
|
Sinqer S, Hofmeister D, Spieqel K and
Boehm A: Current developments in measuring quality of life with
instruments of the European organisation for research and treatment
of cancer (EORTC). Laryngorhinootologie. 90:591–594. 2011.(In
German).
|
|
5
|
Blazeby JM, Conroy T, Hammerlid E, et al;
European Organisation for Research and Treatment of Cancer
Gastrointestinal and Quality of Life Groups. Clinical and
psychometric validation of an EORTC questionnaire module, the EORTC
QLQ-OES18, to assess quality of life in patients with oesophageal
cancer. Eur J Cancer. 39:1384–1394. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chiu PW, Chan AC, Leung SF, et al:
Multicenter prospective randomized trial comparing standard
esophagectomy with chemoradiotherapy for treatment of squamous
esophageal cancer: early results from the Chinese University
Research Group for Esophageal Cancer (CURE). J Gastrointest Surg.
9:794–802. 2005. View Article : Google Scholar
|
|
7
|
Ando N, Ozawa S, Kitagawa Y, et al:
Improvement in the results of surgical treatment of advanced
squamous esophageal carcinoma during 15 consecutive years. Ann
Surg. 232:225–232. 2000.PubMed/NCBI
|
|
8
|
Wilson KS and Lim JT: Primary
chemo-radiotherapy and selective oesophagectomy for oesophageal
cancer: goal of cure with organ preservation. Radiother Oncol.
54:129–134. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rice TW, Adelstein DJ, Chidel MA, et al:
Benefit of postoperative adjuvant chemoradiotherapy in
locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc
Surg. 126:1590–1596. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Courrech Staal EF, van Sandick JW, van
Tinteren H, Cats A and Aaronson NK: Health-related quality of life
in long-term esophageal cancer surviors after potentially curative
treatment. J Thorac Cardiovasc Surg. 140:777–782. 2010.
|
|
11
|
Yap CJ, Malhotra HK and Yang GY: Intensity
modulated radiation therapy in the treatment of esophageal cancer.
Thorac Cancer. 1:62–69. 2010. View Article : Google Scholar
|
|
12
|
Lagergren P, Avery KN, Hughes, et al:
Health-related quality of life among patients cured by surgery for
esophageal cancer. Cancer. 110:686–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Avery KN, Metcalfe C, Barham CP, et al:
Quality of life during potentially curative treatment for locally
advanced oesophageal cancer. Br J Surg. 94:1369–1376. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de Boer AG, van Lanschot JJ, van Sandick
JW, et al: Quality of life after transhiatal compared with extended
transthoracic resection for adenocarcinoma of the esophagus. J Clin
Oncol. 22:4202–4208. 2004.PubMed/NCBI
|
|
15
|
Dancey J, Zee B, Osoba D, et al: Quality
of life scores: an independent prognostic variable in a general
population of cancer patients receiving chemotherapy. The National
Cancer Institute of Canada Clinical Trials Group. Qual Life Res.
6:151–158. 1997. View Article : Google Scholar
|
|
16
|
Blazeby JM, Brookes ST and Alderson D:
Prognostic value of quality of life scores in patients with
oesophageal cancer. Br J Surg. 87:362–373. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang FM, Tsai WL, Chiu HC, et al: Quality
of life as a survival predictor for esophageal squamous cell
carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys.
58:1394–1404. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Johnson JR and Temple R: Food and Drug
Administration requirements for approval of new anticancer drugs.
Cancer Treat Rep. 69:1155–1159. 1985.PubMed/NCBI
|
|
19
|
Homs MY, Essink-Bot ML, Borsboom GJ, et
al; Dutch SIREC Study Group. Quality of life after palliative
treatment for oesophageal carcinoma - a prospective comparison
between stent placement and single dose brachytherapy. Eur J
Cancer. 40:1862–1871. 2004. View Article : Google Scholar
|
|
20
|
de Boer AG, van Lanschot JJ, van Sandick
JW, et al: Quality of life after transhiatal compared with extended
transthoracic resection for adenocarcinoma of the esophagus. J Clin
Oncol. 22:4202–4208. 2004.PubMed/NCBI
|
|
21
|
Roila F and Cortesi E: Quality of life as
a primary end point in oncology. Ann Oncol. 112(Suppl 3): S3–S6.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Winell J and Roth AJ: Depression in cancer
patients. Oncology (Williston Park). 18:1554–1562. 2004.
|
|
23
|
Pasquini M and Biondi M: Depression in
cancer patients: a critical review. Clin Pract Epidemol Ment
Health. 3:22007. View Article : Google Scholar : PubMed/NCBI
|
